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ABSTRACT: The human MDR1 gene is induced by cadmium exposure although no resistance to this metal
is observed in human cells overexpressing hMDR1. To access the role of MDR proteins in cadmium
resistance, human MDR1, Lactococcus lactis lmrA, and Oenococcus oeni omrA were expressed in an
Escherichia coli tolC mutant strain which proved to be hypersensitive to cadmium. Both the human and
bacterial MDR genes conferred cadmium resistance to E. coli up to 0.4 mM concentration. Protection
was abolished by 100 íM verapamil. Quantification of intracellular cadmium concentration by atomic
absorption spectrometry showed a reduced cadmium accumulation in cells expressing the MDR genes.
Inside-out membrane vesicles of L. lactis overexpressing lmrA displayed an ATP-dependent 109Cd2+ uptake
that was stimulated by glutathione. An evolutionary model is discussed in which MDR proteins have
evolved independently from an ancestor protein displaying both organic xenobiotic- and divalent metal-
extrusion abilities.
Multidrug resistance (MDR) is one of the major causes
of failure of chemotherapy employed for the treatment of
cancer (1). Among others, MDR is caused by the over-
expression of a 170 kDa membrane protein called MDR1
or P-glycoprotein (P-gp). MDR1 is a member of the ATP
binding cassette (ABC) superfamily of transporters, whose
functions include the ATP-dependent extrusion of am-
phiphilic compounds out of the cell (1). In addition to MDR1,
other ABC transporters1 have been implicated in MDR in
mammalian cells such as the multidrug resistance associated
protein, MRP1 (2, 3).
Like cancer cells, many organisms have the ability to
develop resistance to a variety of toxic compounds through
ATP-dependent extrusion mechanisms. Indeed, MDR also
occurs in lower eukaryotes and bacteria. For instance,
MDR1-like proteins have been identified in a variety of
aquatic organisms (4) where they can account for the
protection against a broad variety of toxic compounds such
as xenobiotics and naturally occurring toxins, as well as
endogenous toxic compounds. Such transporters can be
relatively specific for a given substrate range or can handle
a wide variety of structurally unrelated compounds. Among
the xenobiotics, heavy metals pose a serious threat to the
environment. Several ABC transporters such as MRP1,
Leishmania LtpgpA, and the yeast cadmium resistance factor
1 (YCF1) may take part in metal resistance. Indeed, these
genuine xenobiotic pumps are also involved in heavy-metal
detoxification: LtpgpA pumps out arsenite and antimony (5),
YCF1 pumps out arsenite, and human MRP1 and YCF1
catalyze the extrusion of bis(glutathionato)cadmium conju-
gates (6, 7).
In our laboratory, we focus on the problem of long-term
pollution in aquatic species by heavy metals such as cadmium
and mercury. In particular, we study resistance mechanisms
against metal contamination displayed by a biological model,
the Asiatic clam Corbicula fluminea. In this bivalve, a gene
encodes a multixenobiotic resistance protein (MXR) that is
homologous to the mammalian P-gp. The MXR protein level
was considerably elevated in the tissues of bivalves living
in a cadmium-contaminated environment (8). Similar obser-
vations have been made in the mussel Mytilus californianus
exposed to arsenite and cadmium (9). Moreover, MRP1 is
overexpressed in human heavy-metal-selected tumor cells
(10), while MDR1 is induced by cadmium and arsenite ions
although no resistance to cadmium ions has been observed
in cells overexpressing P-gp (11). These different examples
suggest that ABC transporters of the MDR group are induced
in the presence of metal contaminants. This raises the
question as to whether these proteins are directly involved
in cellular extrusion of metals in addition to their role as
xenobiotic extruders.
Herein we have analyzed the role of MDR-like proteins
in metallic resistance. Three transporters were tested: the
human hMDR1 and two bacterial ABC-type multidrug
extrusion systems, LmrA and OmrA. LmrA is an ABC
transporter of Lactoccocus lactis (12) that is functionally and
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structurally related to the human MDR1 (13). It uses the free
energy of ATP hydrolysis to drive the export of toxic
compounds from the inner leaflet of the cytoplasmic
membrane (14). Homologues of LmrA have been detected
in other lactic acid bacteria, like the Oenococcus oeni omrA
gene (15). OmrA confers protection to bacteria grown on
high-salt medium. It also triggered bacterial resistance to
sodium laurate, wine, and ethanol toxicity.
To test their ability to provide resistance to toxic metals,
the proteins were expressed in Escherichia coli. All three
systems provided cadmium resistance to E. coli. Transport
assays with inside-out membrane vesicles isolated from L.
lactis suggest an LmrA-mediated cadmium extrusion activity.
EXPERIMENTAL PROCEDURES
Reagents. Cadmium chloride (CdCl2) was purchased from
Merck; reduced glutathione, adenosine 5′-[â,ç-imino]triph-
osphate (AMP-PNP), nisin, and verapamil were from Sigma.
109Cd2+ was purchased from Amersham (Pharmacia, Amer-
sham).
Bacterial Strains, Growth Conditions, and Plasmid Con-
structions. Bacterial strains used were E. coli CS1562 (F-
ì- tolC6::Tn10 his leu proA argT his thi galK lacY trpE non
mtl xyl ara rpsL sup+) (16), E. coli JM109 (e14-(McrA-)
recA1 endA1 gyrA96 thi-1 hsdR17 (rK- mK+) supE44 relA1
¢(lac-proAB) [F′ traD36 proAB lacIq Z¢M15]), E. coli
W3110 (F- ì- thyA36), E. coli BL21(DE3) (B F- dcm ompT
hsdS(rB- mB-) gal ì (DE3)), and L. lactis NZ9000 (¢lmrA,
MG1363 derivative, pepN::nisRK) (17). E. coli was grown
at 37 °C (or 28 °C when transformed with pSF or pSF-MDR)
in LB medium (5 gâL-1 yeast extract, 10 gâL-1 bactotryptone,
10 gâL-1 NaCl) supplemented with the appropriate antibiotic
(ampicillin, kanamycin, or chloramphenicol). L. lactis was
grown at 30 °C in M17 medium (Difco) supplemented with
0.5% glucose and 5 ígâmL-1 chloramphenicol.
The human gene (hMDR1) and two bacterial homologues,
lmrA and omrA, of L. lactis (12) and O. oeni (15),
respectively, were expressed in E. coli strains JM109,
W3110, and BL21 and in strain CS1562, which is hyper-
sensitive to drugs (16) and cadmium (this work, Figure 1B)
due to a deficiency in the TolC protein.
Plasmids used are pSF and pSF-MDR containing an
ampicillin resistance gene (18), pGK13 and pGKLmrA
containing a chloramphenicol resistance gene (12), and pCR-
XL-TOPO (Invitrogen) and pJPB66 (pCR-XL-TOPO) which
harbors the O. oeni omrA gene containing a kanamycin
resistance gene (15).
For the isolation of inside-out membrane vesicles, L. lactis
NZ9000 was transformed with either pNZ8048 (control) or
pNHLmrA (overexpressing lmrA).
Resistance Assays on Agar Media. Overnight cultures with
the appropriate antibiotic were adjusted to an OD660 of 2.
Then, serial 10-fold dilutions were performed, and 5 íL of
each dilution was spotted on the agar medium with or without
cadmium, verapamil, or cadmium and verapamil. The plates
were incubated overnight at 28 or 37 °C and photographed.
Bacterial SurViVal and Metal Quantification. Overnight
cultures were diluted into fresh LB medium (1% v/v)
containing the appropriate antibiotic and grown up to an
OD660 of 0.1. Each culture was divided in three: a control
and two cultures containing 0.25 and 0.4 mM CdCl2,
respectively. Cultures were further incubated for 3 h at 37
°C (or 28 °C for hMDR-transformed bacteria and the
corresponding control). Bacterial survival was determined
as follows: after 3 h, 100 íL of each culture was taken,
serial 10-fold dilutions were plated on LB solid medium,
and colonies were counted after an overnight incubation.
Survival ratios were calculated as the colony-forming units
(cfu) observed in the presence of the metal to that observed
without toxic compound. Cell-associated cadmium levels
were determined as follows: after 3 h of incubation, cells
from 30 mL of culture were collected by centrifugation (15
min, 6000g, 6 °C) and washed with a buffer containing 10
mM TrisâHCl, pH 7.4, and 0.15 mM NaCl. Pellets were
destructed by nitric acid [3 mL of pure HNO3, 65% (v/v)]
in a pressurized medium (borosilicate glass tubes) at 100
°C for 3 h. Samples were diluted with 18 mL of ultrapure
water (MilliQ plus), and cadmium concentrations were
determined by atomic absorption spectrometry with Zeeman
correction, using a graphite tube atomizer (AAS, Thermoptec
M6Solaar). The detection limit was 0.1 íg of CdâL-1 (3 
standard deviation of the reagent blanks). Results were
expressed in nanograms of Cd2+/106 bacteria.
FIGURE 1: E. coli tolC mutant: a suitable strain to study xenobiotic
and metal resistance conferred by expression of MDR transporters.
(A) Effect of TolC on the ethidium bromide resistance introduced
by expression of the hMDR1 transporter. E. coli CS1562 (tolC-)
and JM109 (tolC+) were transformed with plasmids pSF (C) or
pSF-MDR (hMDR1). An equivalent growth pattern was observed
between control and hMDR1-expressing bacteria when the medium
was devoid of ethidium bromide. (B) TolC is involved in cadmium
resistance. Overnight cultures of E. coli CS1562 (tolC-) (open
squares) and JM109 (tolC+) (filled circles) were diluted to an OD660
of 0.06 into LB medium containing various concentrations of
cadmium. Cell growth was monitored as the absorbance at 660 nm
after 12 h of incubation at 37 °C. Measurements were done in
triplicate. Several other tolC+ strains [W3110 and BL21(DE3)] were
tested with similar results for both panels A and B.
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Isolation of Inside-Out Membrane Vesicles from L. lactis.
Inside-out membrane vesicles were isolated from L. lactis
NZ9000 (¢lmrA) cells harboring either pNZ8048 or
pNHLmrA. Cells were grown at 30 °C to an OD660 of about
0.7, whereupon lmrA expression was induced for 1 h by
addition of 0.5 ngâmL-1 nisin (Sigma). Cells were cooled
on ice for 30 min and harvested by centrifugation (6000g
for 8 min) at 4 °C. All subsequent steps were carried out at
the same temperature. Cells were washed twice in 1 L of
ice-cold 100 mM HEPES-KOH, pH 7.4. Pellets were
resuspended in 42 mL of the same buffer. N-Ethylmaleimide
(NEM; Sigma), MgSO4, DNase I (Sigma), and lysozyme
were added to a concentration of 1 mM, 10 mM, 0.1
mgâmL-1, and 10 mgâmL-1, respectively. The cell suspension
was incubated for 45 min at 30 °C, cooled on ice, and lysed
by two successive passages through a French press (20000
psi; Basic Z Model Cell Disrupter, Constant Cell Disruption
Systems). The lysed cells were diluted to a volume of 70
mL with ice-cold HEPES-KOH, pH 7.4, and 1 mM NEM.
Unbroken cells and debris were removed by centrifugations
(13000g for 45 min followed by 25000g for 30 min, 4 °C),
whereupon the membranes were collected from the super-
natant by high-speed centrifugation (125000g for 1 h, 4 °C).
Pellets were resuspended in 1.5 volumes of a buffer
containing 50 mM HEPES-KOH, pH 7.4, 10% glycerol,
and 1 mM NEM, frozen in small aliquots in liquid nitrogen,
and stored at -80 °C.
Protein was assayed according to the method of Lowry
(DC Protein Assay, Bio-Rad), using bovine serum albumin
as a standard.
Transport Assays with 109Cd2+. Membrane vesicles were
added to 1.5 mL of 50 mM HEPES-KOH, pH 7.4, 2 mM
MgSO4, 8.5 mM NaCl, 5 mM phosphocreatine, 0.1 mg/mL
creatine kinase, and 50 íM 109Cd2+ (9.08 íCiâímol-1 specific
activity) in a 5 mL plastic tube to a final concentration of
0.5 mg of protein/mL. After 1 min incubation at 30 °C,
transport was initiated by the addition of 2 mM ATP. When
indicated, 650 íM reduced glutathione and/or 2 mM AMP-
PNP instead of ATP were (was) included in the reaction
mixture. The transport was monitored over 14 min, and at
each time point, 200 íL of the reaction mixture was passed
over cellulose nitrate filters (0.2 íM pore size; BA 83
Schleicher and Schuell) using a vacuum manifold (Trivac
B; Leybold AG, Koln, Germany) under a pressure of 400
millibar. Filters were washed twice with 2 mL of ice-cold
0.1 M LiCl and assayed for radioactivity using a liquid
scintillation analyzer, Tri-carb 2000 CA.
Uptake rates were determined by means of a linear
regression model. In the statistical analysis, a probability of
P < 0.05 was considered significant.
RESULTS
hMDR1, LmrA, and OmrA Proteins Protect Bacteria
against Metal Stress. The difference in in vivo metal ion
susceptibility between E. coli cells harboring the hMDR1-,
lmrA-, or omrA-containing plasmids and bacterial cells
harboring a control plasmid was first studied on solid media.
hMDR1, lmrA, and omrA expression in a tolC- background
resulted in an increased resistance to cadmium chloride which
was manifested by the colony formation at the highest
dilution in the presence of 0.4 mM CdCl2 relative to control.
Verapamil is a well-known inhibitor of MDR-type transport-
ers. It has been shown that verapamil alone exerted no
influence on bacterial growth at 100 íM concentration (19).
In the presence of verapamil all resistance was abolished
(Figure 2), suggesting a MDR-dependent resistance mech-
anism. This resistance phenotype against Cd2+ conferred by
these ABC transporters could only be observed in a tolC-
background. In a tolC+ strain, which resists higher levels of
Cd2+ concentrations than a tolC mutant (Figure 1B), expres-
sion of the ABC transporters did not afford an additional
Cd2+ resistance (Figure 2).
hMDR1, lmrA, and omrA Expression Results in a Lowered
Metal Concentration in Bacteria. Atomic absorption spec-
trometry was used to quantify the cadmium level associated
with Cd-exposed E. coli tolC- cells that were transformed
FIGURE 2: Heterologously expressed ABC MDR transporters in
E. coli confer protection against cadmium toxicity. The E. coli
CS1562 (tolC -) and JM109 (tolC+) strains were transformed with
omrA-, hMDR1-, and lmrA-harboring plasmids and the relevant
control plasmids. (A) pGK13 (C) or pGKLmrA (LmrA). (B)
pCR-XL-TOPO (C) or pJPB66 (OmrA). (C) pSF (C) or pSF-MDR
(hMDR1). An equivalent growth pattern was observed between
control bacteria and transporter-expressing bacteria when the
medium was devoid of CdCl2, while verapamil (100 íM) alone
exerted no influence on bacterial growth. Several other tolC+ strains
[W3110 and BL21(DE3)] were tested and gave similar results.
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with either hMDR1-, lmrA-, omrA-containing plasmids or a
control plasmid. When the culture medium contained 0.25
or 0.4 mM CdCl2, a marked decrease in cell-associated Cd2+
was observed in cells expressing hMDR1, lmrA, or omrA as
compared to the control (Figure 3A,C,E). At 0.4 mM CdCl2,
an 8-, 2-, and 6-fold decrease in cell-associated Cd2+ was
observed with cells expressing hMDR1, lmrA, and omrA,
respectively. This reduction in cell-associated cadmium
correlated with the 4.4-, 1.3-, and 5-fold increases in survival
observed in the cells expressing hMDR1, lmrA, and omrA,
respectively (Figure 3B,D,F). Some differences in cadmium
accumulation were observed among the control cells (bacteria
transformed with empty vectors, Figure 3). However, these
differences likely reflect differences in growth temperature
(in the case of pSF transformed bacteria) or plasmid copy
number (high for pCR-XL-TOPO and low for pGK13).
These data suggest that MDR1, LmrA, and OmrA provide
cadmium resistance to cells through metal pumping.
LmrA-Mediated Cadmium Transport. The increased re-
sistance of cells to cadmium upon expression of MDR
transporters is most likely due to an increased cellular
extrusion of the cadmium. To establish a direct biochemical
demonstration of the ability of the MDR transporter to
extrude cadmium, radioactive cadmium transport experiments
were conduced with inside-out vesicles derived from L. lactis
cells expressing LmrA. The cadmium concentration used in
these experiments was set to 50 íM to facilitate the detection
of the transport activity. This concentration is in the range
of xenobiotic concentrations used in LmrA mechanistic
studies (20). Control membrane vesicles were prepared from
L. lactis NZ9000 (¢lmrA) cells harboring the control plasmid
pNZ8048. Before the addition of ATP, nonspecific cadmium
adsorption was observed with the membrane vesicles. This
behavior is characteristic of divalent metal/membrane inter-
action, since we could also observe Cd2+ binding on dead
or alive E. coli cells within seconds using a cadmium-specific
electrode (data not shown).
109Cd2+ transport was initiated by the addition of 2 mM
ATP. LmrA-containing inside-out vesicles accumulated more
cadmium than the control membranes (Figure 4A). This
difference was calculated to be 30 ( 7 pmol of Cdâmin-1â(mg
of protein)-1 (P < 0.05). To test if cadmium accumulation
is dependent on the hydrolysis of ATP, the same experiment
was performed with the nonhydrolyzable ATP analogue,
FIGURE 3: Heterologously expressed ABC MDR transporters in the E. coli tolC mutant reduce the cell-associated level of cadmium. E. coli
CS1562 (tolC mutant) was transformed with control plasmids and lmrA-, omrA-, and hMDR1-containing plasmids. After 3 h of incubation
with the indicated amount of cadmium, the bacterial cultures were either serially diluted and plated or used for metal quantification. Colonies
were counted, and the survival ratios were calculated as the colony-forming units observed at a given concentration of cadmium to that
observed without added toxic compound (A, C, E). Cell-associated cadmium concentrations were determined by atomic absorption
spectrometry, and results were expressed in ng of Cd2+/106 bacteria (B, D, F). The number of bacteria per digested pellet was determined
by cell numeration. (A, B) Bacteria were transformed with either pGK13 or pGKLmrA. (C, D) Bacteria were transformed with either
pCR-XL-TOPO or pJPB66 (containing the omrA gene). (E, F) Bacteria were transformed with either pSF or pSF-MDR. White bars stand
for survival ratio or Cd2+ associated with control bacteria and black ones for survival ratio or Cd2+ associated with bacteria expressing one
of the ABC transporters.
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AMP-PNP. Again, the difference of 109Cd2+ uptake kinetics
by LmrA-containing vesicles with ATP compared to AMP-
PNP was 30 ( 10 pmol of Cdâmin-1â(mg of protein)-1
(P < 0.05). Moreover, no significant difference of Cd2+
uptake kinetics was observed between the LmrA-containing
vesicles in the presence of AMP-PNP as compared to the
control membranes with ATP. Taken together, these data
suggest that LmrA mediates a low transport activity of Cd2+.
The transport assays were carried out in the absence of
glutathione, cysteine, or other molecules that may form a
thiolate complex with Cd2+. Nevertheless, the assay contains
ATP to drive the LmrA function. ATP may also function as
a cadmium ion vehicle as ABC transporters such as CFTR
or hMDR1 have been shown to pump Mg-ATP (21, 22).
YCF1-catalyzed cadmium extrusion is dependent on glu-
tathione (GSH) and more precisely on the bis(glutathionato)-
cadmium complex (6). Therefore, we addressed the possible
influence of GSH on LmrA-mediated cadmium transport.
109Cd2+ transport by LmrA containing inside-out vesicles was
measured in the presence of ATP with or without 625 íM
GSH and compared with control vesicles (Figure 4B). In
the absence and presence of glutathione, the difference in
transport activity between the LmrA and control membranes
was 28 ( 7 and 124 ( 42 pmol of Cdâmin-1â(mg of
protein)-1, respectively (P < 0.05). This demonstrates that
glutathione stimulates the LmrA-mediated cadmium transport
activity by more than 4-fold.
DISCUSSION
Here we report on the ability of the heterologous expres-
sion of human MDR1 and the bacterial lmrA and omrA genes
to confer resistance in E. coli to cadmium. This study reveals
a novel function of these proteins and provides a mechanistic
explanation for the observation that rat mdr1 overexpression
protects kidney cells against cadmium-mediated apoptosis
(23). Surprisingly, overexpression of human P-gp in renal
carcinoma cells does not result in an increased resistance to
cadmium (11). However, in these cells the activity of P-gp
might have been masked by the activity of MRP proteins.
Indeed, the nematode Caenorhabditis elegans becomes
hypersensitive to heavy metals when both the MRP homo-
logue and a member of the P-pg gene family are deleted
(24).
We noted that the MDR protein mediated cadmium
resistance was only evident in an E. coli strain lacking the
outer membrane protein TolC. Loss of TolC is known to
increase sensitivity to detergents and drugs, but it was
unknown that a tolC mutation also results in an increased
Cd2+ sensitivity. It has been suggested that residual metal
resistance in a strain disrupted in both zntA, a P-type zinc
ATPase, and zitB, a zinc/H+ antiporter of the major facilitor
superfamily, is caused by additional factors or systems (25).
Our studies suggest that one of these factors is TolC (and
possibly associated inner membrane transporters such as
AcrAB) since the MIC for Cd2+ was shifted from 1.1 to 0.35
mM in tolC+ and tolC- strains, respectively. Alternatively,
the pleiotropic effects displayed by the tolC mutant could
explain its increased sensitivity. Resistance to Cd2+ and to
ethidium bromide conferred by MDR transporters was only
observed in a tolC- genetic background (Figure 1A). This
loss of a detectable MDR function in the tolC+ strains
suggests that TolC impedes or masks the ability of these
heterologously expressed MDR proteins to resist Cd. The
latter may be due to the presence of functional and efficient
endogenous cadmium scavenging systems in the TolC-
containing strain.
The present observed cadmium resistance associated with
the three exogenous ABC protein expressions is unlikely the
result of an interaction between these proteins and
endogenous E. coli metal transporters such as the P-type
ATPase ZntA (26). First, the observed bacterial resistance
is abolished by verapamil, while verapamil is not a known
inhibitor of P-type ATPase. Furthermore, verapamil inhibi-
tion of ZntA would lead to a lack of growth at high Cd2+
concentrations [MIC 0.03 mM (27)] whereas growth in the
presence of verapamil was observed at 0.4 mM CdCl2. In
addition, at the concentration used, verapamil exerted no
effect on the colony formation of the control E. coli strains
on solid media, demonstrating that the observed reversal of
metal resistance is not due to inhibition of an endogenous
E. coli system but rather to the inhibition of LmrA, OmrA,
and hMDR1. Second, the LmrA activity is independent from
accessory proteins (20), and murine and human MDR1 genes
have previously been expressed functionally in E. coli
without requirement of an endogenous system or factor (28,
29).
Bacterial resistance to cadmium effected by LmrA, OmrA,
and hMDR1 is also unlikely to be due to a physicochemical
modification of the inner membrane which may in turn
decrease the efficiency of the divalent metal ion uptake
system ZupT (30). First, such an influence on ZupT activity
would have a strong impact on bacterial systems requiring
an optimal supply in Zn2+ and Cu2+ and thus would affect
FIGURE 4: (A) LmrA-mediated ATP-dependent 109Cd2+ uptake in
inside-out membrane vesicles. The uptake of 109Cd2+ by inside-
out vesicles derived from cells that overexpressed LmrA (squares)
or that were devoid of LmrA (diamonds) was measured in the
presence of ATP (filled square/diamond, solid line) or AMP-PNP
(open square, dotted line). Values shown are the means with the
indicated standard deviation (n ) 3). 109Cd2+ was added at time
-1, and reactions were started at time 0 by the addition of ATP or
AMP-PNP. At time 0, the cadmium level was set to 0 to avoid
background related to a nonspecific binding of cadmium to the
membrane vesicles. (B) LmrA-catalyzed uptake of 109Cd2+ is
stimulated by glutathione. The uptake of 109Cd2+ by inside-out
vesicles derived from cells that overexpressed LmrA (filled and
open squares) or control vesicles that were devoid of LmrA (filled
and open diamonds) was measured in the presence of ATP in the
presence (open symbols, thick line) or absence (filled symbols, thin
line) of GSH. Values shown are means ( standard deviation (n )
3). 109Cd2+ and GSH were added 1 min before starting the reaction
by the addition of ATP. At time 0, the cadmium level was set to 0
to avoid background related to a nonspecific binding of cadmium
to the membrane vesicles. The transport activity was defined as
the amount of cadmium taken up during the first 2 min.
5920 Biochemistry, Vol. 44, No. 15, 2005 Achard-Joris et al.
cell activity or growth. We found no difference between the
growth curves of bacteria expressing or devoid of heterolo-
gously expressed MDR-like transporters (data not shown).
Second, it has already been shown that the expression of
the murine MDR1 gene in E. coli is not accompanied by a
dissipation of the protonmotive force as lactose transport by
LacY remained fully functional (28). Also, hMDR1 does not
affect the levels of the protonmotive force when expressed
in mammalian cells (31). Finally, the cellular ATP levels,
as measured by a luminescent assay, were not affected in
the transformed bacteria (data not shown), which shows that
the energy status of the cell is not significantly influenced.
Third, contrary to previous adopted strategies to express the
human and murine MDR1 genes in E. coli (28, 29), we did
not use a strong E. coli promoter to drive the expression of
lmrA-, omrA-, and hMDR1 genes in order to avoid membrane
perturbation by high-level protein expression. Finally, the
sodium dodecyl sulfate sensitivity of MDR-expressing
bacteria was similar to that of control cells, indicating no
major alterations of the cell envelope and membrane (data
not shown).
Quantification of the cadmium level associated with
cadmium-exposed tolC- bacteria (Figure 3) showed that cells
expressing one of the three transporters contained 2 to 8 times
less cadmium than control cells. This strongly suggests that
the ABC proteins extrude Cd-glutathione complexes and,
in the absence of glutathione, Cd-ATP complexes. Direct
evidence for cadmium transport was obtained with membrane
vesicles derived from L. lactis, despite an important LmrA
nonspecific Cd2+ binding. This high background might be
due to the presence of the CadA-like P-type ATPAse YuiA.
In the absence of glutathione, LmrA-containing membranes
showed a cadmium uptake rate of 28 pmolâmin-1â(mg of
protein)-1 above that of control membranes. This transport
rate is in the same order as previously shown for LmrA-
catalyzed transport of daunomycin into inside-out E. coli
membrane vesicles [7.8 pmolâmin-1â(mg of protein)-1] (12).
When glutathione was added to the medium, a more than
4-fold increase in the rate of cadmium transport was observed
up to 124 pmolâmin-1â(mg of protein)-1. Although much
higher rates of cadmium transport have been reported for
the yeast YCF1 (6) in the presence of glutathione [3.3
nmolâmg-1â(mg of protein)-1], it is difficult to directly
compare these rates as they have been determined in vastly
different experimental systems. Unlike YCF1, cadmium
detoxification is likely not the primary function of LmrA.
Among the superfamily of ABC transporters several systems
seem to have evolved to function as efficient metal ion
detoxification devices, such as MRP1, LtpgpA, and YCF1,
while others have retained this activity with only a lower
efficiency.
A weak ATP-dependent LmrA-mediated Cd2+ transport
activity occurred without added glutathione. Under those
conditions, Cd2+ may be complexed with ATP (32) which
was present in large excess. Murine and Drosophila P-gp
homologues have been shown to serve as ATP-conducting
channels in the plasma membrane (21, 33). The cystic fibrosis
transmembrane conductance regulator (CFTR), a chloride
channel that belongs to the ABC superfamily, has also been
demonstrated to conduct ATP movements (22). Finally, the
ZntA ATPase accumulates Cd2+ in inside-out membrane
vesicles 5-fold more efficiently in the presence of cysteine
than in its absence (26). Cd2+, Hg2+, and Zn2+ form
complexes with thiolates with affinities that are several orders
of magnitude greater than complexes with ATP (26). This
may explain the increased LmrA-mediated Cd2+ transport
activity in the presence of glutathione.
A high, nonspecific Cd2+ binding and transport activity
of E. coli membrane vesicles precluded an accurate analysis
of OmrA- and hMDR1-mediated 109Cd transport. However,
given the structural and functional relatedness of OmrA and
hMDR1 with LmrA, and the observation that these systems
render E. coli cells more resistant to Cd2+ with a concomitant
decrease in intracellular cadmium concentrations, it is likely
that OmrA and hMDR1 also extrude Cd2+. These systems
have more in common. First, both LmrA and OmrA were
shown to protect bacteria against sodium laurate toxicity and
ethanol and wine shocks (15). Second, both CFTR and MDR
proteins share ATP- and chloride-channel activity (21, 22,
34). Third, CFTR is able to release glutathione into airway
surface fluid (35) and then displays functional similarity with
the ABC proteins MRP1, MRP2, and YCF1 (2, 3, 6). Fourth,
overexpression of CFTR leads to a multidrug resistance
phenotype (36). And vice versa, induction by antitumoral
drugs of hMDR1 and hMRP1 complements CFTR function
(37). These results raise the possibility that ABC transporters
may be interchanged, as outlined by the complementary
patterns of expression of the CFTR and hMDR1 genes
observed in vivo (38). The common functional features in
ABC transporters are likely to be explained by an early
evolutionary event. ABC genes may have evolved separately
and acquired a more specialized activity, while maintaining
their general function with low efficiency. For instance,
hMDR1, LmrA, and OmrA proteins are specialized in
xenobiotic scavenging but still are able to confer some
resistance against metals. In the future, it would be valuable
to determine the selectivity of such proteins among heavy
metals.
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